Pyridazinyl phenyl hydrazones useful against congestive heart failure
CA 2403188 A1 · Owner: Backstrom, Reijo · Inventors: Haikala, Heimo; Pippuri, Aino; Kaivola, Juha
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Therapeutically active compounds of formula (I) in which R1 to R4 means hydrogen, alkyl, alkenyl, aryl, arylalkyl carboxyalkyl, hydroxyalkyl or , halogenalkyl or R2 and R3 form a ring of 5-7 carbon atoms R5 to R9 means , hydrogen, alkyl, alkenyl aryl, arylalkyl, acyl, hydroxy, alkoxy alkoxycarbonyl, amino, acylamino, alkylamino aryloxy, halogen, cyano, nitro, carboxy alkylsulfonyl, sulfonamido or trifluoromethyl wherein each aryl , residue defined above by itself or as a part of another group may be substituted, and pharmaceutically acceptable salts and esters thereof. The compounds increase the calcium sensitivity of contractile proteins of the cardiac muscle and are thus useful in the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 12, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 12, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 12, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.